ACGI (Amacore Group) Debt-to-EBITDA : -0.10 (As of Jun. 2010)


What is Amacore Group Debt-to-EBITDA?

Amacore Group ACGI Debt-to-EBITDA is -0.10 as of Jun. 2010.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Amacore Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2010 was $0.93 Mil. Amacore Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2010 was $1.77 Mil. Amacore Group's annualized EBITDA for the quarter that ended in Jun. 2010 was $-26.64 Mil. Amacore Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2010 was -0.10.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Amacore Group's Debt-to-EBITDA or its related term are showing as below:

ACGI's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.21
* Ranked among companies with meaningful Debt-to-EBITDA only.

Amacore Group  (OTCPK:ACGI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Amacore Group Debt-to-EBITDA Related Terms


Amacore Group Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Amacore Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amacore Group Debt-to-EBITDA Chart

Amacore Group Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.26 -0.95 -0.07 -0.11 -0.31

Amacore Group Quarterly Data
Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 -0.09 -0.17 -0.70 -0.10

ACGI vs ASNB, UNISQ, QTXB: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Amacore Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amacore Group Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Amacore Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Amacore Group's Debt-to-EBITDA falls into.



Amacore Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Amacore Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2009 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.026 + 1.826) / -9.183
=-0.31

Amacore Group's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2010 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.928 + 1.767) / -26.636
=-0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2010) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -0.10 mean?
Amacore Group (ACGI) has a Debt-to-EBITDA of -0.10 as of Jun. 2010. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Amacore Group.
Is Amacore Group's Debt-to-EBITDA too high?
Amacore Group's current Debt-to-EBITDA is -0.10.
How does Amacore Group's Debt-to-EBITDA compare to ASNB and UNISQ?
Amacore Group's Debt-to-EBITDA of -0.10 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-EBITDA is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 475 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Amacore Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amacore Group's current Debt-to-EBITDA is -0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amacore Group stock overvalued right now?
Amacore Group (ACGI) has a current Debt-to-EBITDA of -0.10. The current Debt-to-EBITDA is -0.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Amacore Group (ACGI), the current Debt-to-EBITDA is -0.10 as of Jun. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amacore Group Business Description

Address Maitland Promenade 1, Suite 450, 485 North Keller Road, Maitland, FL, USA, 32751
Amacore Group Inc provides and markets healthcare-related membership products such as limited and major medical insurance programs, supplemental medical insurance and discount dental and vision programs for individuals and families. It offers services through agents, sales representatives, and marketing partners.